Talcid (Hydrotalcite, BAY4516H) + Famotidine + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn
Trial Timeline
May 1, 2003 → Feb 1, 2004
NCT ID
NCT01928888About Talcid (Hydrotalcite, BAY4516H) + Famotidine + Placebo
Talcid (Hydrotalcite, BAY4516H) + Famotidine + Placebo is a approved stage product being developed by Bayer for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT01928888. Target conditions include Heartburn.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01928888 | Approved | Completed |
Competing Products
20 competing products in Heartburn